Effectiveness of a Low Carbohydrate Diet Versus a High Carbohydrate Diet in Promoting Weight Loss and Improved Health

Phase 2CompletedNCT00200720

Kaiser Permanente260 enrolled

Overview

This study will examine the effects of a low carbohydrate diet versus a high carbohydrate diet on weight loss.

The number of overweight and obese Americans has increased significantly in recent years. There are now many different diet plans being promoted by doctors and the media. The Atkins diet, a low carbohydrate nutritional plan, is especially popular; its advocates claim that following the diet will result in long-term weight loss with no negative effects. Another diet, called the Dietary Approaches to Stop Hypertension (DASH) diet, is a high carbohydrate diet designed to help treat and prevent high blood pressure. However, more thorough investigation of these claims is needed. This study will compare the short- and long-term effects of the Atkins diet to the (DASH) diet. This trial will enroll overweight and obese participants. This study will last 30 months and will comprise two phases. Participants will be randomly assigned to either the Atkins or DASH diet for 30 months. During Phase 1, all participants will undergo 6 months of weekly group therapy to encourage weight loss. Phase 2 is a weight loss maintenance phase. During Phase 2, participants will have monthly meetings with a therapist for weight loss support. Study visits will occur at study entry and at Months 3 and 30. At each study visit, weight measurements, blood and urine collection, and x-rays will occur to determine participants' weight loss, cardiovascular health, kidney function, and bone density.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

260

Conditions

Obesity Hypertension

Interventions

Atkins diet (low carbohydrate diet)BEHAVIORAL

DASH diet (high carbohydrate diet)BEHAVIORAL

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Body mass index (BMI) of 27 to 50 * Fasting glucose less than 126 mg/dl * Total fasting cholesterol less than 260 mg/dl * Total fasting triglycerides less than 400 mg/dl * Permission of primary care provider to participate in the study * Normal liver and kidney function * Willing to modify diet and other health behaviors * Willing to use an acceptable method of contraception for the duration of the study Exclusion Criteria: * Any medical condition that may make weight loss medically inadvisable * Weigh more than 400 lbs * History of kidney failure * Current use of more than 3 blood pressure medications * Change in blood pressure medications within 3 months prior to study entry * Diagnosis of cardiovascular disease within 6 months prior to study entry * Cancer diagnosis within 2 years of study entry. Participants with basal cell skin cancer are not excluded. * History of psychiatric hospitalization within 2 years prior to study entry * Consumption of more than three alcoholic drinks a day * Type I or II diabetes * Current use of hypolipidemics, antipsychotics, hypoglycemics, glucocorticoids, or thyroid medication * Plan to move during study * Current participation in another clinical trial * Pregnancy or breastfeeding

Locations (1)

Kaiser Permanente Center for Health Research

Portland, Oregon, United States

Outcomes

Primary Outcomes

Weight loss

Excess weight loss (greater than 5 pounds a week)would trigger patient assessment.

Time frame: monthly

Secondary Outcomes

Risk of cardiovascular disease

Elevated lipids or rising blood pressure during six month safety assessments would trigger additional participant evaluation

Time frame: Every six months

bone health

Time frame: end of study

kidney function

Time frame: every six months

neuroendocrine mechanisms of hunger and satiety

Time frame: end of study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.